Key facts
- This page summarizes Michael Holder's Form 4 filing for Cytek Biosciences, Inc. (CTKB).
- 4 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 12 Jun 2026, 19:22.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Options Exercise
Additional SEC filing notes
Footnote F1
Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
100% of the shares subject to the RSU Award shall vest on the earlier of June 10, 2027 and the date of the Issuer's 2027 annual meeting of stockholders (provided such meeting is held in June 2027).
Footnote F3
100% of the shares subject to the option shall vest on the earlier of June 10, 2027 and the date of the Issuer's 2027 annual meeting of stockholders (provided such meeting is held in June 2027).
Footnote F4
100% of the shares subject to the RSU Award vested on June 10, 2026.